Global Serum and Plasma Proteomics Service Market Growth (Status and Outlook) 2026-2032
The global Serum and Plasma Proteomics Service market size is predicted to grow from US$ 731 million in 2025 to US$ 1632 million in 2032; it is expected to grow at a CAGR of 12.5% from 2026 to 2032.
Serum and Plasma Proteomics Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Serum and Plasma Proteomics Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Serum and Plasma Proteomics Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Serum and Plasma Proteomics Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Serum and Plasma Proteomics Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
LPI (LP Information)' newest research report, the “Serum and Plasma Proteomics Service Industry Forecast” looks at past sales and reviews total world Serum and Plasma Proteomics Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Serum and Plasma Proteomics Service sales for 2026 through 2032. With Serum and Plasma Proteomics Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serum and Plasma Proteomics Service industry.
This Insight Report provides a comprehensive analysis of the global Serum and Plasma Proteomics Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Serum and Plasma Proteomics Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Serum and Plasma Proteomics Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serum and Plasma Proteomics Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serum and Plasma Proteomics Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Serum and Plasma Proteomics Service market by product type, application, key players and key regions and countries.
Serum and Plasma Proteomics Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Serum and Plasma Proteomics Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Serum and Plasma Proteomics Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Serum and Plasma Proteomics Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Serum and Plasma Proteomics Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
LPI (LP Information)' newest research report, the “Serum and Plasma Proteomics Service Industry Forecast” looks at past sales and reviews total world Serum and Plasma Proteomics Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Serum and Plasma Proteomics Service sales for 2026 through 2032. With Serum and Plasma Proteomics Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serum and Plasma Proteomics Service industry.
This Insight Report provides a comprehensive analysis of the global Serum and Plasma Proteomics Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Serum and Plasma Proteomics Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Serum and Plasma Proteomics Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serum and Plasma Proteomics Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serum and Plasma Proteomics Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Serum and Plasma Proteomics Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Plasma Proteomics Analysis Service
- Serum Proteomics Analysis Service
Segmentation by End User:
- Universities and Research Institutes
- Hospitals
- Pharmaceutical Companies
- Others
Segmentation by Research Areas:
- Oncology
- Cardiovascular
- Agriculture
- Neuroscience
- Other
Segmentation by Application:
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Serum and Plasma Proteomics Service Market Size (2021-2032)
2.1.2 Serum and Plasma Proteomics Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Serum and Plasma Proteomics Service by Country/Region (2021, 2025 & 2032)
2.2 Serum and Plasma Proteomics Service Segment by Type
2.2.1 Plasma Proteomics Analysis Service
2.2.2 Serum Proteomics Analysis Service
2.2.3 Serum and Plasma Proteomics Service Market Size by Type
2.2.3.1 Serum and Plasma Proteomics Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
2.3 Serum and Plasma Proteomics Service Segment by End User
2.3.1 Universities and Research Institutes
2.3.2 Hospitals
2.3.3 Pharmaceutical Companies
2.3.4 Others
2.3.5 Serum and Plasma Proteomics Service Market Size by End User
2.3.5.1 Serum and Plasma Proteomics Service Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.3.5.2 Global Serum and Plasma Proteomics Service Market Size Market Share by End User (2021-2026)
2.4 Serum and Plasma Proteomics Service Segment by Research Areas
2.4.1 Oncology
2.4.2 Cardiovascular
2.4.3 Agriculture
2.4.4 Neuroscience
2.4.5 Other
2.4.6 Serum and Plasma Proteomics Service Market Size by Research Areas
2.4.6.1 Serum and Plasma Proteomics Service Market Size CAGR by Research Areas (2021 VS 2025 VS 2032)
2.4.6.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas (2021-2026)
2.5 Serum and Plasma Proteomics Service Segment by Application
2.5.1 Disease Biomarker Research
2.5.2 Drug Development
2.5.3 Clinical Research
2.5.4 Others
2.5.5 Serum and Plasma Proteomics Service Market Size by Application
2.5.5.1 Serum and Plasma Proteomics Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
3 SERUM AND PLASMA PROTEOMICS SERVICE MARKET SIZE BY PLAYER
3.1 Serum and Plasma Proteomics Service Market Size Market Share by Player
3.1.1 Global Serum and Plasma Proteomics Service Revenue by Player (2021-2026)
3.1.2 Global Serum and Plasma Proteomics Service Revenue Market Share by Player (2021-2026)
3.2 Global Serum and Plasma Proteomics Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SERUM AND PLASMA PROTEOMICS SERVICE BY REGION
4.1 Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
4.2 Global Serum and Plasma Proteomics Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.4 APAC Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.5 Europe Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
5.2 Americas Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
5.3 Americas Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
6.2 APAC Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
6.3 APAC Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
7.2 Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
7.3 Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Serum and Plasma Proteomics Service by Region (2021-2026)
8.2 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SERUM AND PLASMA PROTEOMICS SERVICE MARKET FORECAST
10.1 Global Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.1.1 Global Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.1.2 Americas Serum and Plasma Proteomics Service Forecast
10.1.3 APAC Serum and Plasma Proteomics Service Forecast
10.1.4 Europe Serum and Plasma Proteomics Service Forecast
10.1.5 Middle East & Africa Serum and Plasma Proteomics Service Forecast
10.2 Americas Serum and Plasma Proteomics Service Forecast by Country (2027-2032)
10.2.1 United States Market Serum and Plasma Proteomics Service Forecast
10.2.2 Canada Market Serum and Plasma Proteomics Service Forecast
10.2.3 Mexico Market Serum and Plasma Proteomics Service Forecast
10.2.4 Brazil Market Serum and Plasma Proteomics Service Forecast
10.3 APAC Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.3.1 China Serum and Plasma Proteomics Service Market Forecast
10.3.2 Japan Market Serum and Plasma Proteomics Service Forecast
10.3.3 Korea Market Serum and Plasma Proteomics Service Forecast
10.3.4 Southeast Asia Market Serum and Plasma Proteomics Service Forecast
10.3.5 India Market Serum and Plasma Proteomics Service Forecast
10.3.6 Australia Market Serum and Plasma Proteomics Service Forecast
10.4 Europe Serum and Plasma Proteomics Service Forecast by Country (2027-2032)
10.4.1 Germany Market Serum and Plasma Proteomics Service Forecast
10.4.2 France Market Serum and Plasma Proteomics Service Forecast
10.4.3 UK Market Serum and Plasma Proteomics Service Forecast
10.4.4 Italy Market Serum and Plasma Proteomics Service Forecast
10.4.5 Russia Market Serum and Plasma Proteomics Service Forecast
10.5 Middle East & Africa Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Serum and Plasma Proteomics Service Forecast
10.5.2 South Africa Market Serum and Plasma Proteomics Service Forecast
10.5.3 Israel Market Serum and Plasma Proteomics Service Forecast
10.5.4 Turkey Market Serum and Plasma Proteomics Service Forecast
10.6 Global Serum and Plasma Proteomics Service Forecast by Type (2027-2032)
10.7 Global Serum and Plasma Proteomics Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Serum and Plasma Proteomics Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Olink (Thermo Fisher Scientific)
11.1.1 Olink (Thermo Fisher Scientific) Company Information
11.1.2 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Offered
11.1.3 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Olink (Thermo Fisher Scientific) Main Business Overview
11.1.5 Olink (Thermo Fisher Scientific) Latest Developments
11.2 SomaLogic (Illumina)
11.2.1 SomaLogic (Illumina) Company Information
11.2.2 SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Offered
11.2.3 SomaLogic (Illumina) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 SomaLogic (Illumina) Main Business Overview
11.2.5 SomaLogic (Illumina) Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Serum and Plasma Proteomics Service Product Offered
11.3.3 Labcorp Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 BostonGene
11.4.1 BostonGene Company Information
11.4.2 BostonGene Serum and Plasma Proteomics Service Product Offered
11.4.3 BostonGene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BostonGene Main Business Overview
11.4.5 BostonGene Latest Developments
11.5 CellCarta
11.5.1 CellCarta Company Information
11.5.2 CellCarta Serum and Plasma Proteomics Service Product Offered
11.5.3 CellCarta Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CellCarta Main Business Overview
11.5.5 CellCarta Latest Developments
11.6 GENEWIZ (Azenta Life Sciences)
11.6.1 GENEWIZ (Azenta Life Sciences) Company Information
11.6.2 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Offered
11.6.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GENEWIZ (Azenta Life Sciences) Main Business Overview
11.6.5 GENEWIZ (Azenta Life Sciences) Latest Developments
11.7 CDI Labs
11.7.1 CDI Labs Company Information
11.7.2 CDI Labs Serum and Plasma Proteomics Service Product Offered
11.7.3 CDI Labs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CDI Labs Main Business Overview
11.7.5 CDI Labs Latest Developments
11.8 Biognosys
11.8.1 Biognosys Company Information
11.8.2 Biognosys Serum and Plasma Proteomics Service Product Offered
11.8.3 Biognosys Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biognosys Main Business Overview
11.8.5 Biognosys Latest Developments
11.9 Discovery Life Sciences
11.9.1 Discovery Life Sciences Company Information
11.9.2 Discovery Life Sciences Serum and Plasma Proteomics Service Product Offered
11.9.3 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Discovery Life Sciences Main Business Overview
11.9.5 Discovery Life Sciences Latest Developments
11.10 Firalis Molecular Precision
11.10.1 Firalis Molecular Precision Company Information
11.10.2 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Offered
11.10.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Firalis Molecular Precision Main Business Overview
11.10.5 Firalis Molecular Precision Latest Developments
11.11 Cell Signaling Technology (CST)
11.11.1 Cell Signaling Technology (CST) Company Information
11.11.2 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Offered
11.11.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cell Signaling Technology (CST) Main Business Overview
11.11.5 Cell Signaling Technology (CST) Latest Developments
11.12 Sampled (Infinity Biologix)
11.12.1 Sampled (Infinity Biologix) Company Information
11.12.2 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Offered
11.12.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sampled (Infinity Biologix) Main Business Overview
11.12.5 Sampled (Infinity Biologix) Latest Developments
11.13 APTBIO
11.13.1 APTBIO Company Information
11.13.2 APTBIO Serum and Plasma Proteomics Service Product Offered
11.13.3 APTBIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 APTBIO Main Business Overview
11.13.5 APTBIO Latest Developments
11.14 Sinotech Genomics
11.14.1 Sinotech Genomics Company Information
11.14.2 Sinotech Genomics Serum and Plasma Proteomics Service Product Offered
11.14.3 Sinotech Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Sinotech Genomics Main Business Overview
11.14.5 Sinotech Genomics Latest Developments
11.15 Biodesix
11.15.1 Biodesix Company Information
11.15.2 Biodesix Serum and Plasma Proteomics Service Product Offered
11.15.3 Biodesix Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Biodesix Main Business Overview
11.15.5 Biodesix Latest Developments
11.16 Panome Bio
11.16.1 Panome Bio Company Information
11.16.2 Panome Bio Serum and Plasma Proteomics Service Product Offered
11.16.3 Panome Bio Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Panome Bio Main Business Overview
11.16.5 Panome Bio Latest Developments
11.17 Novogene
11.17.1 Novogene Company Information
11.17.2 Novogene Serum and Plasma Proteomics Service Product Offered
11.17.3 Novogene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Novogene Main Business Overview
11.17.5 Novogene Latest Developments
11.18 PTM BIO
11.18.1 PTM BIO Company Information
11.18.2 PTM BIO Serum and Plasma Proteomics Service Product Offered
11.18.3 PTM BIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 PTM BIO Main Business Overview
11.18.5 PTM BIO Latest Developments
11.19 BGI Genomics
11.19.1 BGI Genomics Company Information
11.19.2 BGI Genomics Serum and Plasma Proteomics Service Product Offered
11.19.3 BGI Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 BGI Genomics Main Business Overview
11.19.5 BGI Genomics Latest Developments
11.20 Evotec
11.20.1 Evotec Company Information
11.20.2 Evotec Serum and Plasma Proteomics Service Product Offered
11.20.3 Evotec Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Evotec Main Business Overview
11.20.5 Evotec Latest Developments
11.21 Metware Biotechnology
11.21.1 Metware Biotechnology Company Information
11.21.2 Metware Biotechnology Serum and Plasma Proteomics Service Product Offered
11.21.3 Metware Biotechnology Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Metware Biotechnology Main Business Overview
11.21.5 Metware Biotechnology Latest Developments
11.22 MRM Proteomics
11.22.1 MRM Proteomics Company Information
11.22.2 MRM Proteomics Serum and Plasma Proteomics Service Product Offered
11.22.3 MRM Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 MRM Proteomics Main Business Overview
11.22.5 MRM Proteomics Latest Developments
11.23 Lc-Bio Technologies
11.23.1 Lc-Bio Technologies Company Information
11.23.2 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Offered
11.23.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Lc-Bio Technologies Main Business Overview
11.23.5 Lc-Bio Technologies Latest Developments
11.24 Eurofins Scientific
11.24.1 Eurofins Scientific Company Information
11.24.2 Eurofins Scientific Serum and Plasma Proteomics Service Product Offered
11.24.3 Eurofins Scientific Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Eurofins Scientific Main Business Overview
11.24.5 Eurofins Scientific Latest Developments
11.25 MtoZ-Biolabs
11.25.1 MtoZ-Biolabs Company Information
11.25.2 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Offered
11.25.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 MtoZ-Biolabs Main Business Overview
11.25.5 MtoZ-Biolabs Latest Developments
11.26 Creative Proteomics
11.26.1 Creative Proteomics Company Information
11.26.2 Creative Proteomics Serum and Plasma Proteomics Service Product Offered
11.26.3 Creative Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Creative Proteomics Main Business Overview
11.26.5 Creative Proteomics Latest Developments
11.27 Macrogen
11.27.1 Macrogen Company Information
11.27.2 Macrogen Serum and Plasma Proteomics Service Product Offered
11.27.3 Macrogen Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Macrogen Main Business Overview
11.27.5 Macrogen Latest Developments
11.28 TATAA Biocenter
11.28.1 TATAA Biocenter Company Information
11.28.2 TATAA Biocenter Serum and Plasma Proteomics Service Product Offered
11.28.3 TATAA Biocenter Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 TATAA Biocenter Main Business Overview
11.28.5 TATAA Biocenter Latest Developments
11.29 OmicScouts (Momentum Biotechnologies)
11.29.1 OmicScouts (Momentum Biotechnologies) Company Information
11.29.2 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Offered
11.29.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 OmicScouts (Momentum Biotechnologies) Main Business Overview
11.29.5 OmicScouts (Momentum Biotechnologies) Latest Developments
11.30 Precision Biomarker Laboratories (PBL)
11.30.1 Precision Biomarker Laboratories (PBL) Company Information
11.30.2 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Offered
11.30.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Precision Biomarker Laboratories (PBL) Main Business Overview
11.30.5 Precision Biomarker Laboratories (PBL) Latest Developments
11.31 Shanghai OE Biotech
11.31.1 Shanghai OE Biotech Company Information
11.31.2 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Offered
11.31.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Shanghai OE Biotech Main Business Overview
11.31.5 Shanghai OE Biotech Latest Developments
11.32 RxCelerate
11.32.1 RxCelerate Company Information
11.32.2 RxCelerate Serum and Plasma Proteomics Service Product Offered
11.32.3 RxCelerate Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 RxCelerate Main Business Overview
11.32.5 RxCelerate Latest Developments
11.33 Proteomics International
11.33.1 Proteomics International Company Information
11.33.2 Proteomics International Serum and Plasma Proteomics Service Product Offered
11.33.3 Proteomics International Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Proteomics International Main Business Overview
11.33.5 Proteomics International Latest Developments
11.34 Proteome Sciences
11.34.1 Proteome Sciences Company Information
11.34.2 Proteome Sciences Serum and Plasma Proteomics Service Product Offered
11.34.3 Proteome Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Proteome Sciences Main Business Overview
11.34.5 Proteome Sciences Latest Developments
11.35 Westlake Omics
11.35.1 Westlake Omics Company Information
11.35.2 Westlake Omics Serum and Plasma Proteomics Service Product Offered
11.35.3 Westlake Omics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Westlake Omics Main Business Overview
11.35.5 Westlake Omics Latest Developments
11.36 Crown Bioscience
11.36.1 Crown Bioscience Company Information
11.36.2 Crown Bioscience Serum and Plasma Proteomics Service Product Offered
11.36.3 Crown Bioscience Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 Crown Bioscience Main Business Overview
11.36.5 Crown Bioscience Latest Developments
11.37 VProteomics
11.37.1 VProteomics Company Information
11.37.2 VProteomics Serum and Plasma Proteomics Service Product Offered
11.37.3 VProteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 VProteomics Main Business Overview
11.37.5 VProteomics Latest Developments
11.38 Shanghai Majorbio Bio-Pharm
11.38.1 Shanghai Majorbio Bio-Pharm Company Information
11.38.2 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Offered
11.38.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Shanghai Majorbio Bio-Pharm Main Business Overview
11.38.5 Shanghai Majorbio Bio-Pharm Latest Developments
11.39 Applied Biomics
11.39.1 Applied Biomics Company Information
11.39.2 Applied Biomics Serum and Plasma Proteomics Service Product Offered
11.39.3 Applied Biomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Applied Biomics Main Business Overview
11.39.5 Applied Biomics Latest Developments
11.40 Sapient Bioanalytics
11.40.1 Sapient Bioanalytics Company Information
11.40.2 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Offered
11.40.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.40.4 Sapient Bioanalytics Main Business Overview
11.40.5 Sapient Bioanalytics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Serum and Plasma Proteomics Service Market Size (2021-2032)
2.1.2 Serum and Plasma Proteomics Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Serum and Plasma Proteomics Service by Country/Region (2021, 2025 & 2032)
2.2 Serum and Plasma Proteomics Service Segment by Type
2.2.1 Plasma Proteomics Analysis Service
2.2.2 Serum Proteomics Analysis Service
2.2.3 Serum and Plasma Proteomics Service Market Size by Type
2.2.3.1 Serum and Plasma Proteomics Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
2.3 Serum and Plasma Proteomics Service Segment by End User
2.3.1 Universities and Research Institutes
2.3.2 Hospitals
2.3.3 Pharmaceutical Companies
2.3.4 Others
2.3.5 Serum and Plasma Proteomics Service Market Size by End User
2.3.5.1 Serum and Plasma Proteomics Service Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.3.5.2 Global Serum and Plasma Proteomics Service Market Size Market Share by End User (2021-2026)
2.4 Serum and Plasma Proteomics Service Segment by Research Areas
2.4.1 Oncology
2.4.2 Cardiovascular
2.4.3 Agriculture
2.4.4 Neuroscience
2.4.5 Other
2.4.6 Serum and Plasma Proteomics Service Market Size by Research Areas
2.4.6.1 Serum and Plasma Proteomics Service Market Size CAGR by Research Areas (2021 VS 2025 VS 2032)
2.4.6.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas (2021-2026)
2.5 Serum and Plasma Proteomics Service Segment by Application
2.5.1 Disease Biomarker Research
2.5.2 Drug Development
2.5.3 Clinical Research
2.5.4 Others
2.5.5 Serum and Plasma Proteomics Service Market Size by Application
2.5.5.1 Serum and Plasma Proteomics Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
3 SERUM AND PLASMA PROTEOMICS SERVICE MARKET SIZE BY PLAYER
3.1 Serum and Plasma Proteomics Service Market Size Market Share by Player
3.1.1 Global Serum and Plasma Proteomics Service Revenue by Player (2021-2026)
3.1.2 Global Serum and Plasma Proteomics Service Revenue Market Share by Player (2021-2026)
3.2 Global Serum and Plasma Proteomics Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SERUM AND PLASMA PROTEOMICS SERVICE BY REGION
4.1 Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
4.2 Global Serum and Plasma Proteomics Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.4 APAC Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.5 Europe Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Serum and Plasma Proteomics Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
5.2 Americas Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
5.3 Americas Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Serum and Plasma Proteomics Service Market Size by Region (2021-2026)
6.2 APAC Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
6.3 APAC Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026)
7.2 Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
7.3 Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Serum and Plasma Proteomics Service by Region (2021-2026)
8.2 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SERUM AND PLASMA PROTEOMICS SERVICE MARKET FORECAST
10.1 Global Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.1.1 Global Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.1.2 Americas Serum and Plasma Proteomics Service Forecast
10.1.3 APAC Serum and Plasma Proteomics Service Forecast
10.1.4 Europe Serum and Plasma Proteomics Service Forecast
10.1.5 Middle East & Africa Serum and Plasma Proteomics Service Forecast
10.2 Americas Serum and Plasma Proteomics Service Forecast by Country (2027-2032)
10.2.1 United States Market Serum and Plasma Proteomics Service Forecast
10.2.2 Canada Market Serum and Plasma Proteomics Service Forecast
10.2.3 Mexico Market Serum and Plasma Proteomics Service Forecast
10.2.4 Brazil Market Serum and Plasma Proteomics Service Forecast
10.3 APAC Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.3.1 China Serum and Plasma Proteomics Service Market Forecast
10.3.2 Japan Market Serum and Plasma Proteomics Service Forecast
10.3.3 Korea Market Serum and Plasma Proteomics Service Forecast
10.3.4 Southeast Asia Market Serum and Plasma Proteomics Service Forecast
10.3.5 India Market Serum and Plasma Proteomics Service Forecast
10.3.6 Australia Market Serum and Plasma Proteomics Service Forecast
10.4 Europe Serum and Plasma Proteomics Service Forecast by Country (2027-2032)
10.4.1 Germany Market Serum and Plasma Proteomics Service Forecast
10.4.2 France Market Serum and Plasma Proteomics Service Forecast
10.4.3 UK Market Serum and Plasma Proteomics Service Forecast
10.4.4 Italy Market Serum and Plasma Proteomics Service Forecast
10.4.5 Russia Market Serum and Plasma Proteomics Service Forecast
10.5 Middle East & Africa Serum and Plasma Proteomics Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Serum and Plasma Proteomics Service Forecast
10.5.2 South Africa Market Serum and Plasma Proteomics Service Forecast
10.5.3 Israel Market Serum and Plasma Proteomics Service Forecast
10.5.4 Turkey Market Serum and Plasma Proteomics Service Forecast
10.6 Global Serum and Plasma Proteomics Service Forecast by Type (2027-2032)
10.7 Global Serum and Plasma Proteomics Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Serum and Plasma Proteomics Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Olink (Thermo Fisher Scientific)
11.1.1 Olink (Thermo Fisher Scientific) Company Information
11.1.2 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Offered
11.1.3 Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Olink (Thermo Fisher Scientific) Main Business Overview
11.1.5 Olink (Thermo Fisher Scientific) Latest Developments
11.2 SomaLogic (Illumina)
11.2.1 SomaLogic (Illumina) Company Information
11.2.2 SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Offered
11.2.3 SomaLogic (Illumina) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 SomaLogic (Illumina) Main Business Overview
11.2.5 SomaLogic (Illumina) Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Serum and Plasma Proteomics Service Product Offered
11.3.3 Labcorp Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 BostonGene
11.4.1 BostonGene Company Information
11.4.2 BostonGene Serum and Plasma Proteomics Service Product Offered
11.4.3 BostonGene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BostonGene Main Business Overview
11.4.5 BostonGene Latest Developments
11.5 CellCarta
11.5.1 CellCarta Company Information
11.5.2 CellCarta Serum and Plasma Proteomics Service Product Offered
11.5.3 CellCarta Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CellCarta Main Business Overview
11.5.5 CellCarta Latest Developments
11.6 GENEWIZ (Azenta Life Sciences)
11.6.1 GENEWIZ (Azenta Life Sciences) Company Information
11.6.2 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Offered
11.6.3 GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GENEWIZ (Azenta Life Sciences) Main Business Overview
11.6.5 GENEWIZ (Azenta Life Sciences) Latest Developments
11.7 CDI Labs
11.7.1 CDI Labs Company Information
11.7.2 CDI Labs Serum and Plasma Proteomics Service Product Offered
11.7.3 CDI Labs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CDI Labs Main Business Overview
11.7.5 CDI Labs Latest Developments
11.8 Biognosys
11.8.1 Biognosys Company Information
11.8.2 Biognosys Serum and Plasma Proteomics Service Product Offered
11.8.3 Biognosys Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biognosys Main Business Overview
11.8.5 Biognosys Latest Developments
11.9 Discovery Life Sciences
11.9.1 Discovery Life Sciences Company Information
11.9.2 Discovery Life Sciences Serum and Plasma Proteomics Service Product Offered
11.9.3 Discovery Life Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Discovery Life Sciences Main Business Overview
11.9.5 Discovery Life Sciences Latest Developments
11.10 Firalis Molecular Precision
11.10.1 Firalis Molecular Precision Company Information
11.10.2 Firalis Molecular Precision Serum and Plasma Proteomics Service Product Offered
11.10.3 Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Firalis Molecular Precision Main Business Overview
11.10.5 Firalis Molecular Precision Latest Developments
11.11 Cell Signaling Technology (CST)
11.11.1 Cell Signaling Technology (CST) Company Information
11.11.2 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Offered
11.11.3 Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cell Signaling Technology (CST) Main Business Overview
11.11.5 Cell Signaling Technology (CST) Latest Developments
11.12 Sampled (Infinity Biologix)
11.12.1 Sampled (Infinity Biologix) Company Information
11.12.2 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Offered
11.12.3 Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sampled (Infinity Biologix) Main Business Overview
11.12.5 Sampled (Infinity Biologix) Latest Developments
11.13 APTBIO
11.13.1 APTBIO Company Information
11.13.2 APTBIO Serum and Plasma Proteomics Service Product Offered
11.13.3 APTBIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 APTBIO Main Business Overview
11.13.5 APTBIO Latest Developments
11.14 Sinotech Genomics
11.14.1 Sinotech Genomics Company Information
11.14.2 Sinotech Genomics Serum and Plasma Proteomics Service Product Offered
11.14.3 Sinotech Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Sinotech Genomics Main Business Overview
11.14.5 Sinotech Genomics Latest Developments
11.15 Biodesix
11.15.1 Biodesix Company Information
11.15.2 Biodesix Serum and Plasma Proteomics Service Product Offered
11.15.3 Biodesix Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Biodesix Main Business Overview
11.15.5 Biodesix Latest Developments
11.16 Panome Bio
11.16.1 Panome Bio Company Information
11.16.2 Panome Bio Serum and Plasma Proteomics Service Product Offered
11.16.3 Panome Bio Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Panome Bio Main Business Overview
11.16.5 Panome Bio Latest Developments
11.17 Novogene
11.17.1 Novogene Company Information
11.17.2 Novogene Serum and Plasma Proteomics Service Product Offered
11.17.3 Novogene Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Novogene Main Business Overview
11.17.5 Novogene Latest Developments
11.18 PTM BIO
11.18.1 PTM BIO Company Information
11.18.2 PTM BIO Serum and Plasma Proteomics Service Product Offered
11.18.3 PTM BIO Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 PTM BIO Main Business Overview
11.18.5 PTM BIO Latest Developments
11.19 BGI Genomics
11.19.1 BGI Genomics Company Information
11.19.2 BGI Genomics Serum and Plasma Proteomics Service Product Offered
11.19.3 BGI Genomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 BGI Genomics Main Business Overview
11.19.5 BGI Genomics Latest Developments
11.20 Evotec
11.20.1 Evotec Company Information
11.20.2 Evotec Serum and Plasma Proteomics Service Product Offered
11.20.3 Evotec Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Evotec Main Business Overview
11.20.5 Evotec Latest Developments
11.21 Metware Biotechnology
11.21.1 Metware Biotechnology Company Information
11.21.2 Metware Biotechnology Serum and Plasma Proteomics Service Product Offered
11.21.3 Metware Biotechnology Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Metware Biotechnology Main Business Overview
11.21.5 Metware Biotechnology Latest Developments
11.22 MRM Proteomics
11.22.1 MRM Proteomics Company Information
11.22.2 MRM Proteomics Serum and Plasma Proteomics Service Product Offered
11.22.3 MRM Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 MRM Proteomics Main Business Overview
11.22.5 MRM Proteomics Latest Developments
11.23 Lc-Bio Technologies
11.23.1 Lc-Bio Technologies Company Information
11.23.2 Lc-Bio Technologies Serum and Plasma Proteomics Service Product Offered
11.23.3 Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Lc-Bio Technologies Main Business Overview
11.23.5 Lc-Bio Technologies Latest Developments
11.24 Eurofins Scientific
11.24.1 Eurofins Scientific Company Information
11.24.2 Eurofins Scientific Serum and Plasma Proteomics Service Product Offered
11.24.3 Eurofins Scientific Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Eurofins Scientific Main Business Overview
11.24.5 Eurofins Scientific Latest Developments
11.25 MtoZ-Biolabs
11.25.1 MtoZ-Biolabs Company Information
11.25.2 MtoZ-Biolabs Serum and Plasma Proteomics Service Product Offered
11.25.3 MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 MtoZ-Biolabs Main Business Overview
11.25.5 MtoZ-Biolabs Latest Developments
11.26 Creative Proteomics
11.26.1 Creative Proteomics Company Information
11.26.2 Creative Proteomics Serum and Plasma Proteomics Service Product Offered
11.26.3 Creative Proteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Creative Proteomics Main Business Overview
11.26.5 Creative Proteomics Latest Developments
11.27 Macrogen
11.27.1 Macrogen Company Information
11.27.2 Macrogen Serum and Plasma Proteomics Service Product Offered
11.27.3 Macrogen Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Macrogen Main Business Overview
11.27.5 Macrogen Latest Developments
11.28 TATAA Biocenter
11.28.1 TATAA Biocenter Company Information
11.28.2 TATAA Biocenter Serum and Plasma Proteomics Service Product Offered
11.28.3 TATAA Biocenter Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 TATAA Biocenter Main Business Overview
11.28.5 TATAA Biocenter Latest Developments
11.29 OmicScouts (Momentum Biotechnologies)
11.29.1 OmicScouts (Momentum Biotechnologies) Company Information
11.29.2 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Offered
11.29.3 OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 OmicScouts (Momentum Biotechnologies) Main Business Overview
11.29.5 OmicScouts (Momentum Biotechnologies) Latest Developments
11.30 Precision Biomarker Laboratories (PBL)
11.30.1 Precision Biomarker Laboratories (PBL) Company Information
11.30.2 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Offered
11.30.3 Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Precision Biomarker Laboratories (PBL) Main Business Overview
11.30.5 Precision Biomarker Laboratories (PBL) Latest Developments
11.31 Shanghai OE Biotech
11.31.1 Shanghai OE Biotech Company Information
11.31.2 Shanghai OE Biotech Serum and Plasma Proteomics Service Product Offered
11.31.3 Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Shanghai OE Biotech Main Business Overview
11.31.5 Shanghai OE Biotech Latest Developments
11.32 RxCelerate
11.32.1 RxCelerate Company Information
11.32.2 RxCelerate Serum and Plasma Proteomics Service Product Offered
11.32.3 RxCelerate Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 RxCelerate Main Business Overview
11.32.5 RxCelerate Latest Developments
11.33 Proteomics International
11.33.1 Proteomics International Company Information
11.33.2 Proteomics International Serum and Plasma Proteomics Service Product Offered
11.33.3 Proteomics International Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Proteomics International Main Business Overview
11.33.5 Proteomics International Latest Developments
11.34 Proteome Sciences
11.34.1 Proteome Sciences Company Information
11.34.2 Proteome Sciences Serum and Plasma Proteomics Service Product Offered
11.34.3 Proteome Sciences Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Proteome Sciences Main Business Overview
11.34.5 Proteome Sciences Latest Developments
11.35 Westlake Omics
11.35.1 Westlake Omics Company Information
11.35.2 Westlake Omics Serum and Plasma Proteomics Service Product Offered
11.35.3 Westlake Omics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Westlake Omics Main Business Overview
11.35.5 Westlake Omics Latest Developments
11.36 Crown Bioscience
11.36.1 Crown Bioscience Company Information
11.36.2 Crown Bioscience Serum and Plasma Proteomics Service Product Offered
11.36.3 Crown Bioscience Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 Crown Bioscience Main Business Overview
11.36.5 Crown Bioscience Latest Developments
11.37 VProteomics
11.37.1 VProteomics Company Information
11.37.2 VProteomics Serum and Plasma Proteomics Service Product Offered
11.37.3 VProteomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 VProteomics Main Business Overview
11.37.5 VProteomics Latest Developments
11.38 Shanghai Majorbio Bio-Pharm
11.38.1 Shanghai Majorbio Bio-Pharm Company Information
11.38.2 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Offered
11.38.3 Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Shanghai Majorbio Bio-Pharm Main Business Overview
11.38.5 Shanghai Majorbio Bio-Pharm Latest Developments
11.39 Applied Biomics
11.39.1 Applied Biomics Company Information
11.39.2 Applied Biomics Serum and Plasma Proteomics Service Product Offered
11.39.3 Applied Biomics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Applied Biomics Main Business Overview
11.39.5 Applied Biomics Latest Developments
11.40 Sapient Bioanalytics
11.40.1 Sapient Bioanalytics Company Information
11.40.2 Sapient Bioanalytics Serum and Plasma Proteomics Service Product Offered
11.40.3 Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue, Gross Margin and Market Share (2021-2026)
11.40.4 Sapient Bioanalytics Main Business Overview
11.40.5 Sapient Bioanalytics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Serum and Plasma Proteomics Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Serum and Plasma Proteomics Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plasma Proteomics Analysis Service
Table 4. Major Players of Serum Proteomics Analysis Service
Table 5. Serum and Plasma Proteomics Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Universities and Research Institutes
Table 9. Major Players of Hospitals
Table 10. Major Players of Pharmaceutical Companies
Table 11. Major Players of Others
Table 12. Serum and Plasma Proteomics Service Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Serum and Plasma Proteomics Service Market Size by End User (2021-2026) & ($ millions)
Table 14. Global Serum and Plasma Proteomics Service Market Size Market Share by End User (2021-2026)
Table 15. Major Players of Oncology
Table 16. Major Players of Cardiovascular
Table 17. Major Players of Agriculture
Table 18. Major Players of Neuroscience
Table 19. Major Players of Other
Table 20. Serum and Plasma Proteomics Service Market Size CAGR by Research Areas (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Serum and Plasma Proteomics Service Market Size by Research Areas (2021-2026) & ($ millions)
Table 22. Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas (2021-2026)
Table 23. Serum and Plasma Proteomics Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Table 26. Global Serum and Plasma Proteomics Service Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Serum and Plasma Proteomics Service Revenue Market Share by Player (2021-2026)
Table 28. Serum and Plasma Proteomics Service Key Players Head office and Products Offered
Table 29. Serum and Plasma Proteomics Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Table 34. Global Serum and Plasma Proteomics Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Serum and Plasma Proteomics Service Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Serum and Plasma Proteomics Service Market Size Market Share by Country (2021-2026)
Table 38. Americas Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Table 40. Americas Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Table 42. APAC Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Table 44. APAC Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Serum and Plasma Proteomics Service Market Size Market Share by Country (2021-2026)
Table 48. Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Serum and Plasma Proteomics Service
Table 54. Key Market Challenges & Risks of Serum and Plasma Proteomics Service
Table 55. Key Industry Trends of Serum and Plasma Proteomics Service
Table 56. Global Serum and Plasma Proteomics Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Serum and Plasma Proteomics Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Serum and Plasma Proteomics Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Olink (Thermo Fisher Scientific) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 61. Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Offered
Table 62. Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Olink (Thermo Fisher Scientific) Main Business
Table 64. Olink (Thermo Fisher Scientific) Latest Developments
Table 65. SomaLogic (Illumina) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 66. SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Offered
Table 67. SomaLogic (Illumina) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. SomaLogic (Illumina) Main Business
Table 69. SomaLogic (Illumina) Latest Developments
Table 70. Labcorp Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 71. Labcorp Serum and Plasma Proteomics Service Product Offered
Table 72. Labcorp Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Labcorp Main Business
Table 74. Labcorp Latest Developments
Table 75. BostonGene Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 76. BostonGene Serum and Plasma Proteomics Service Product Offered
Table 77. BostonGene Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BostonGene Main Business
Table 79. BostonGene Latest Developments
Table 80. CellCarta Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 81. CellCarta Serum and Plasma Proteomics Service Product Offered
Table 82. CellCarta Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. CellCarta Main Business
Table 84. CellCarta Latest Developments
Table 85. GENEWIZ (Azenta Life Sciences) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 86. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Offered
Table 87. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. GENEWIZ (Azenta Life Sciences) Main Business
Table 89. GENEWIZ (Azenta Life Sciences) Latest Developments
Table 90. CDI Labs Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 91. CDI Labs Serum and Plasma Proteomics Service Product Offered
Table 92. CDI Labs Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CDI Labs Main Business
Table 94. CDI Labs Latest Developments
Table 95. Biognosys Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 96. Biognosys Serum and Plasma Proteomics Service Product Offered
Table 97. Biognosys Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Biognosys Main Business
Table 99. Biognosys Latest Developments
Table 100. Discovery Life Sciences Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 101. Discovery Life Sciences Serum and Plasma Proteomics Service Product Offered
Table 102. Discovery Life Sciences Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Discovery Life Sciences Main Business
Table 104. Discovery Life Sciences Latest Developments
Table 105. Firalis Molecular Precision Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 106. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Offered
Table 107. Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Firalis Molecular Precision Main Business
Table 109. Firalis Molecular Precision Latest Developments
Table 110. Cell Signaling Technology (CST) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 111. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Offered
Table 112. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Cell Signaling Technology (CST) Main Business
Table 114. Cell Signaling Technology (CST) Latest Developments
Table 115. Sampled (Infinity Biologix) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 116. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Offered
Table 117. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Sampled (Infinity Biologix) Main Business
Table 119. Sampled (Infinity Biologix) Latest Developments
Table 120. APTBIO Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 121. APTBIO Serum and Plasma Proteomics Service Product Offered
Table 122. APTBIO Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. APTBIO Main Business
Table 124. APTBIO Latest Developments
Table 125. Sinotech Genomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 126. Sinotech Genomics Serum and Plasma Proteomics Service Product Offered
Table 127. Sinotech Genomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Sinotech Genomics Main Business
Table 129. Sinotech Genomics Latest Developments
Table 130. Biodesix Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 131. Biodesix Serum and Plasma Proteomics Service Product Offered
Table 132. Biodesix Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Biodesix Main Business
Table 134. Biodesix Latest Developments
Table 135. Panome Bio Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 136. Panome Bio Serum and Plasma Proteomics Service Product Offered
Table 137. Panome Bio Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Panome Bio Main Business
Table 139. Panome Bio Latest Developments
Table 140. Novogene Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 141. Novogene Serum and Plasma Proteomics Service Product Offered
Table 142. Novogene Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Novogene Main Business
Table 144. Novogene Latest Developments
Table 145. PTM BIO Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 146. PTM BIO Serum and Plasma Proteomics Service Product Offered
Table 147. PTM BIO Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. PTM BIO Main Business
Table 149. PTM BIO Latest Developments
Table 150. BGI Genomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 151. BGI Genomics Serum and Plasma Proteomics Service Product Offered
Table 152. BGI Genomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. BGI Genomics Main Business
Table 154. BGI Genomics Latest Developments
Table 155. Evotec Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 156. Evotec Serum and Plasma Proteomics Service Product Offered
Table 157. Evotec Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Evotec Main Business
Table 159. Evotec Latest Developments
Table 160. Metware Biotechnology Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 161. Metware Biotechnology Serum and Plasma Proteomics Service Product Offered
Table 162. Metware Biotechnology Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Metware Biotechnology Main Business
Table 164. Metware Biotechnology Latest Developments
Table 165. MRM Proteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 166. MRM Proteomics Serum and Plasma Proteomics Service Product Offered
Table 167. MRM Proteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. MRM Proteomics Main Business
Table 169. MRM Proteomics Latest Developments
Table 170. Lc-Bio Technologies Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 171. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Offered
Table 172. Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 173. Lc-Bio Technologies Main Business
Table 174. Lc-Bio Technologies Latest Developments
Table 175. Eurofins Scientific Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 176. Eurofins Scientific Serum and Plasma Proteomics Service Product Offered
Table 177. Eurofins Scientific Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 178. Eurofins Scientific Main Business
Table 179. Eurofins Scientific Latest Developments
Table 180. MtoZ-Biolabs Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 181. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Offered
Table 182. MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 183. MtoZ-Biolabs Main Business
Table 184. MtoZ-Biolabs Latest Developments
Table 185. Creative Proteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 186. Creative Proteomics Serum and Plasma Proteomics Service Product Offered
Table 187. Creative Proteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 188. Creative Proteomics Main Business
Table 189. Creative Proteomics Latest Developments
Table 190. Macrogen Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 191. Macrogen Serum and Plasma Proteomics Service Product Offered
Table 192. Macrogen Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 193. Macrogen Main Business
Table 194. Macrogen Latest Developments
Table 195. TATAA Biocenter Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 196. TATAA Biocenter Serum and Plasma Proteomics Service Product Offered
Table 197. TATAA Biocenter Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 198. TATAA Biocenter Main Business
Table 199. TATAA Biocenter Latest Developments
Table 200. OmicScouts (Momentum Biotechnologies) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 201. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Offered
Table 202. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 203. OmicScouts (Momentum Biotechnologies) Main Business
Table 204. OmicScouts (Momentum Biotechnologies) Latest Developments
Table 205. Precision Biomarker Laboratories (PBL) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 206. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Offered
Table 207. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 208. Precision Biomarker Laboratories (PBL) Main Business
Table 209. Precision Biomarker Laboratories (PBL) Latest Developments
Table 210. Shanghai OE Biotech Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 211. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Offered
Table 212. Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 213. Shanghai OE Biotech Main Business
Table 214. Shanghai OE Biotech Latest Developments
Table 215. RxCelerate Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 216. RxCelerate Serum and Plasma Proteomics Service Product Offered
Table 217. RxCelerate Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 218. RxCelerate Main Business
Table 219. RxCelerate Latest Developments
Table 220. Proteomics International Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 221. Proteomics International Serum and Plasma Proteomics Service Product Offered
Table 222. Proteomics International Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 223. Proteomics International Main Business
Table 224. Proteomics International Latest Developments
Table 225. Proteome Sciences Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 226. Proteome Sciences Serum and Plasma Proteomics Service Product Offered
Table 227. Proteome Sciences Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 228. Proteome Sciences Main Business
Table 229. Proteome Sciences Latest Developments
Table 230. Westlake Omics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 231. Westlake Omics Serum and Plasma Proteomics Service Product Offered
Table 232. Westlake Omics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 233. Westlake Omics Main Business
Table 234. Westlake Omics Latest Developments
Table 235. Crown Bioscience Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 236. Crown Bioscience Serum and Plasma Proteomics Service Product Offered
Table 237. Crown Bioscience Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 238. Crown Bioscience Main Business
Table 239. Crown Bioscience Latest Developments
Table 240. VProteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 241. VProteomics Serum and Plasma Proteomics Service Product Offered
Table 242. VProteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 243. VProteomics Main Business
Table 244. VProteomics Latest Developments
Table 245. Shanghai Majorbio Bio-Pharm Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 246. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Offered
Table 247. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 248. Shanghai Majorbio Bio-Pharm Main Business
Table 249. Shanghai Majorbio Bio-Pharm Latest Developments
Table 250. Applied Biomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 251. Applied Biomics Serum and Plasma Proteomics Service Product Offered
Table 252. Applied Biomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 253. Applied Biomics Main Business
Table 254. Applied Biomics Latest Developments
Table 255. Sapient Bioanalytics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 256. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Offered
Table 257. Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 258. Sapient Bioanalytics Main Business
Table 259. Sapient Bioanalytics Latest Developments
Table 1. Serum and Plasma Proteomics Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Serum and Plasma Proteomics Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Plasma Proteomics Analysis Service
Table 4. Major Players of Serum Proteomics Analysis Service
Table 5. Serum and Plasma Proteomics Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Universities and Research Institutes
Table 9. Major Players of Hospitals
Table 10. Major Players of Pharmaceutical Companies
Table 11. Major Players of Others
Table 12. Serum and Plasma Proteomics Service Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Serum and Plasma Proteomics Service Market Size by End User (2021-2026) & ($ millions)
Table 14. Global Serum and Plasma Proteomics Service Market Size Market Share by End User (2021-2026)
Table 15. Major Players of Oncology
Table 16. Major Players of Cardiovascular
Table 17. Major Players of Agriculture
Table 18. Major Players of Neuroscience
Table 19. Major Players of Other
Table 20. Serum and Plasma Proteomics Service Market Size CAGR by Research Areas (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Serum and Plasma Proteomics Service Market Size by Research Areas (2021-2026) & ($ millions)
Table 22. Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas (2021-2026)
Table 23. Serum and Plasma Proteomics Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Table 26. Global Serum and Plasma Proteomics Service Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Serum and Plasma Proteomics Service Revenue Market Share by Player (2021-2026)
Table 28. Serum and Plasma Proteomics Service Key Players Head office and Products Offered
Table 29. Serum and Plasma Proteomics Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Table 34. Global Serum and Plasma Proteomics Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Serum and Plasma Proteomics Service Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Serum and Plasma Proteomics Service Market Size Market Share by Country (2021-2026)
Table 38. Americas Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Table 40. Americas Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Table 42. APAC Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Table 44. APAC Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Serum and Plasma Proteomics Service Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Serum and Plasma Proteomics Service Market Size Market Share by Country (2021-2026)
Table 48. Europe Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Serum and Plasma Proteomics Service Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Serum and Plasma Proteomics Service
Table 54. Key Market Challenges & Risks of Serum and Plasma Proteomics Service
Table 55. Key Industry Trends of Serum and Plasma Proteomics Service
Table 56. Global Serum and Plasma Proteomics Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Serum and Plasma Proteomics Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Serum and Plasma Proteomics Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Olink (Thermo Fisher Scientific) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 61. Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Product Offered
Table 62. Olink (Thermo Fisher Scientific) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Olink (Thermo Fisher Scientific) Main Business
Table 64. Olink (Thermo Fisher Scientific) Latest Developments
Table 65. SomaLogic (Illumina) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 66. SomaLogic (Illumina) Serum and Plasma Proteomics Service Product Offered
Table 67. SomaLogic (Illumina) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. SomaLogic (Illumina) Main Business
Table 69. SomaLogic (Illumina) Latest Developments
Table 70. Labcorp Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 71. Labcorp Serum and Plasma Proteomics Service Product Offered
Table 72. Labcorp Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Labcorp Main Business
Table 74. Labcorp Latest Developments
Table 75. BostonGene Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 76. BostonGene Serum and Plasma Proteomics Service Product Offered
Table 77. BostonGene Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BostonGene Main Business
Table 79. BostonGene Latest Developments
Table 80. CellCarta Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 81. CellCarta Serum and Plasma Proteomics Service Product Offered
Table 82. CellCarta Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. CellCarta Main Business
Table 84. CellCarta Latest Developments
Table 85. GENEWIZ (Azenta Life Sciences) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 86. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Product Offered
Table 87. GENEWIZ (Azenta Life Sciences) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. GENEWIZ (Azenta Life Sciences) Main Business
Table 89. GENEWIZ (Azenta Life Sciences) Latest Developments
Table 90. CDI Labs Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 91. CDI Labs Serum and Plasma Proteomics Service Product Offered
Table 92. CDI Labs Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CDI Labs Main Business
Table 94. CDI Labs Latest Developments
Table 95. Biognosys Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 96. Biognosys Serum and Plasma Proteomics Service Product Offered
Table 97. Biognosys Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Biognosys Main Business
Table 99. Biognosys Latest Developments
Table 100. Discovery Life Sciences Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 101. Discovery Life Sciences Serum and Plasma Proteomics Service Product Offered
Table 102. Discovery Life Sciences Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Discovery Life Sciences Main Business
Table 104. Discovery Life Sciences Latest Developments
Table 105. Firalis Molecular Precision Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 106. Firalis Molecular Precision Serum and Plasma Proteomics Service Product Offered
Table 107. Firalis Molecular Precision Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Firalis Molecular Precision Main Business
Table 109. Firalis Molecular Precision Latest Developments
Table 110. Cell Signaling Technology (CST) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 111. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Product Offered
Table 112. Cell Signaling Technology (CST) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Cell Signaling Technology (CST) Main Business
Table 114. Cell Signaling Technology (CST) Latest Developments
Table 115. Sampled (Infinity Biologix) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 116. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Product Offered
Table 117. Sampled (Infinity Biologix) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Sampled (Infinity Biologix) Main Business
Table 119. Sampled (Infinity Biologix) Latest Developments
Table 120. APTBIO Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 121. APTBIO Serum and Plasma Proteomics Service Product Offered
Table 122. APTBIO Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. APTBIO Main Business
Table 124. APTBIO Latest Developments
Table 125. Sinotech Genomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 126. Sinotech Genomics Serum and Plasma Proteomics Service Product Offered
Table 127. Sinotech Genomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Sinotech Genomics Main Business
Table 129. Sinotech Genomics Latest Developments
Table 130. Biodesix Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 131. Biodesix Serum and Plasma Proteomics Service Product Offered
Table 132. Biodesix Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Biodesix Main Business
Table 134. Biodesix Latest Developments
Table 135. Panome Bio Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 136. Panome Bio Serum and Plasma Proteomics Service Product Offered
Table 137. Panome Bio Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Panome Bio Main Business
Table 139. Panome Bio Latest Developments
Table 140. Novogene Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 141. Novogene Serum and Plasma Proteomics Service Product Offered
Table 142. Novogene Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Novogene Main Business
Table 144. Novogene Latest Developments
Table 145. PTM BIO Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 146. PTM BIO Serum and Plasma Proteomics Service Product Offered
Table 147. PTM BIO Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. PTM BIO Main Business
Table 149. PTM BIO Latest Developments
Table 150. BGI Genomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 151. BGI Genomics Serum and Plasma Proteomics Service Product Offered
Table 152. BGI Genomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. BGI Genomics Main Business
Table 154. BGI Genomics Latest Developments
Table 155. Evotec Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 156. Evotec Serum and Plasma Proteomics Service Product Offered
Table 157. Evotec Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Evotec Main Business
Table 159. Evotec Latest Developments
Table 160. Metware Biotechnology Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 161. Metware Biotechnology Serum and Plasma Proteomics Service Product Offered
Table 162. Metware Biotechnology Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Metware Biotechnology Main Business
Table 164. Metware Biotechnology Latest Developments
Table 165. MRM Proteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 166. MRM Proteomics Serum and Plasma Proteomics Service Product Offered
Table 167. MRM Proteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. MRM Proteomics Main Business
Table 169. MRM Proteomics Latest Developments
Table 170. Lc-Bio Technologies Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 171. Lc-Bio Technologies Serum and Plasma Proteomics Service Product Offered
Table 172. Lc-Bio Technologies Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 173. Lc-Bio Technologies Main Business
Table 174. Lc-Bio Technologies Latest Developments
Table 175. Eurofins Scientific Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 176. Eurofins Scientific Serum and Plasma Proteomics Service Product Offered
Table 177. Eurofins Scientific Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 178. Eurofins Scientific Main Business
Table 179. Eurofins Scientific Latest Developments
Table 180. MtoZ-Biolabs Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 181. MtoZ-Biolabs Serum and Plasma Proteomics Service Product Offered
Table 182. MtoZ-Biolabs Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 183. MtoZ-Biolabs Main Business
Table 184. MtoZ-Biolabs Latest Developments
Table 185. Creative Proteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 186. Creative Proteomics Serum and Plasma Proteomics Service Product Offered
Table 187. Creative Proteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 188. Creative Proteomics Main Business
Table 189. Creative Proteomics Latest Developments
Table 190. Macrogen Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 191. Macrogen Serum and Plasma Proteomics Service Product Offered
Table 192. Macrogen Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 193. Macrogen Main Business
Table 194. Macrogen Latest Developments
Table 195. TATAA Biocenter Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 196. TATAA Biocenter Serum and Plasma Proteomics Service Product Offered
Table 197. TATAA Biocenter Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 198. TATAA Biocenter Main Business
Table 199. TATAA Biocenter Latest Developments
Table 200. OmicScouts (Momentum Biotechnologies) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 201. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Product Offered
Table 202. OmicScouts (Momentum Biotechnologies) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 203. OmicScouts (Momentum Biotechnologies) Main Business
Table 204. OmicScouts (Momentum Biotechnologies) Latest Developments
Table 205. Precision Biomarker Laboratories (PBL) Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 206. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Product Offered
Table 207. Precision Biomarker Laboratories (PBL) Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 208. Precision Biomarker Laboratories (PBL) Main Business
Table 209. Precision Biomarker Laboratories (PBL) Latest Developments
Table 210. Shanghai OE Biotech Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 211. Shanghai OE Biotech Serum and Plasma Proteomics Service Product Offered
Table 212. Shanghai OE Biotech Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 213. Shanghai OE Biotech Main Business
Table 214. Shanghai OE Biotech Latest Developments
Table 215. RxCelerate Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 216. RxCelerate Serum and Plasma Proteomics Service Product Offered
Table 217. RxCelerate Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 218. RxCelerate Main Business
Table 219. RxCelerate Latest Developments
Table 220. Proteomics International Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 221. Proteomics International Serum and Plasma Proteomics Service Product Offered
Table 222. Proteomics International Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 223. Proteomics International Main Business
Table 224. Proteomics International Latest Developments
Table 225. Proteome Sciences Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 226. Proteome Sciences Serum and Plasma Proteomics Service Product Offered
Table 227. Proteome Sciences Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 228. Proteome Sciences Main Business
Table 229. Proteome Sciences Latest Developments
Table 230. Westlake Omics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 231. Westlake Omics Serum and Plasma Proteomics Service Product Offered
Table 232. Westlake Omics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 233. Westlake Omics Main Business
Table 234. Westlake Omics Latest Developments
Table 235. Crown Bioscience Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 236. Crown Bioscience Serum and Plasma Proteomics Service Product Offered
Table 237. Crown Bioscience Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 238. Crown Bioscience Main Business
Table 239. Crown Bioscience Latest Developments
Table 240. VProteomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 241. VProteomics Serum and Plasma Proteomics Service Product Offered
Table 242. VProteomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 243. VProteomics Main Business
Table 244. VProteomics Latest Developments
Table 245. Shanghai Majorbio Bio-Pharm Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 246. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Product Offered
Table 247. Shanghai Majorbio Bio-Pharm Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 248. Shanghai Majorbio Bio-Pharm Main Business
Table 249. Shanghai Majorbio Bio-Pharm Latest Developments
Table 250. Applied Biomics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 251. Applied Biomics Serum and Plasma Proteomics Service Product Offered
Table 252. Applied Biomics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 253. Applied Biomics Main Business
Table 254. Applied Biomics Latest Developments
Table 255. Sapient Bioanalytics Details, Company Type, Serum and Plasma Proteomics Service Area Served and Its Competitors
Table 256. Sapient Bioanalytics Serum and Plasma Proteomics Service Product Offered
Table 257. Sapient Bioanalytics Serum and Plasma Proteomics Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 258. Sapient Bioanalytics Main Business
Table 259. Sapient Bioanalytics Latest Developments
LIST OF FIGURES
Figure 1. Serum and Plasma Proteomics Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Serum and Plasma Proteomics Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Serum and Plasma Proteomics Service Sales Market Share by Country/Region (2025)
Figure 8. Serum and Plasma Proteomics Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Serum and Plasma Proteomics Service Market Size Market Share by Type in 2025
Figure 10. Global Serum and Plasma Proteomics Service Market Size Market Share by End User in 2025
Figure 11. Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas in 2025
Figure 12. Serum and Plasma Proteomics Service in Disease Biomarker Research
Figure 13. Global Serum and Plasma Proteomics Service Market: Disease Biomarker Research (2021-2026) & ($ millions)
Figure 14. Serum and Plasma Proteomics Service in Drug Development
Figure 15. Global Serum and Plasma Proteomics Service Market: Drug Development (2021-2026) & ($ millions)
Figure 16. Serum and Plasma Proteomics Service in Clinical Research
Figure 17. Global Serum and Plasma Proteomics Service Market: Clinical Research (2021-2026) & ($ millions)
Figure 18. Serum and Plasma Proteomics Service in Others
Figure 19. Global Serum and Plasma Proteomics Service Market: Others (2021-2026) & ($ millions)
Figure 20. Global Serum and Plasma Proteomics Service Market Size Market Share by Application in 2025
Figure 21. Global Serum and Plasma Proteomics Service Revenue Market Share by Player in 2025
Figure 22. Global Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Figure 23. Americas Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 24. APAC Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 25. Europe Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 27. Americas Serum and Plasma Proteomics Service Value Market Share by Country in 2025
Figure 28. United States Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Serum and Plasma Proteomics Service Market Size Market Share by Region in 2025
Figure 33. APAC Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 34. APAC Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 35. China Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 39. India Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Serum and Plasma Proteomics Service Market Size Market Share by Country in 2025
Figure 42. Europe Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 43. Europe Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 44. Germany Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 45. France Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 58. APAC Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 59. Europe Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 61. United States Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 62. Canada Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 63. Mexico Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 64. Brazil Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 65. China Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 66. Japan Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 67. Korea Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 69. India Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 70. Australia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 71. Germany Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 72. France Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 73. UK Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 74. Italy Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 75. Russia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 76. Egypt Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 77. South Africa Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 78. Israel Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 79. Turkey Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 80. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 1. Serum and Plasma Proteomics Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Serum and Plasma Proteomics Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Serum and Plasma Proteomics Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Serum and Plasma Proteomics Service Sales Market Share by Country/Region (2025)
Figure 8. Serum and Plasma Proteomics Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Serum and Plasma Proteomics Service Market Size Market Share by Type in 2025
Figure 10. Global Serum and Plasma Proteomics Service Market Size Market Share by End User in 2025
Figure 11. Global Serum and Plasma Proteomics Service Market Size Market Share by Research Areas in 2025
Figure 12. Serum and Plasma Proteomics Service in Disease Biomarker Research
Figure 13. Global Serum and Plasma Proteomics Service Market: Disease Biomarker Research (2021-2026) & ($ millions)
Figure 14. Serum and Plasma Proteomics Service in Drug Development
Figure 15. Global Serum and Plasma Proteomics Service Market: Drug Development (2021-2026) & ($ millions)
Figure 16. Serum and Plasma Proteomics Service in Clinical Research
Figure 17. Global Serum and Plasma Proteomics Service Market: Clinical Research (2021-2026) & ($ millions)
Figure 18. Serum and Plasma Proteomics Service in Others
Figure 19. Global Serum and Plasma Proteomics Service Market: Others (2021-2026) & ($ millions)
Figure 20. Global Serum and Plasma Proteomics Service Market Size Market Share by Application in 2025
Figure 21. Global Serum and Plasma Proteomics Service Revenue Market Share by Player in 2025
Figure 22. Global Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Figure 23. Americas Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 24. APAC Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 25. Europe Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Serum and Plasma Proteomics Service Market Size 2021-2026 ($ millions)
Figure 27. Americas Serum and Plasma Proteomics Service Value Market Share by Country in 2025
Figure 28. United States Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Serum and Plasma Proteomics Service Market Size Market Share by Region in 2025
Figure 33. APAC Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 34. APAC Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 35. China Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 39. India Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Serum and Plasma Proteomics Service Market Size Market Share by Country in 2025
Figure 42. Europe Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 43. Europe Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 44. Germany Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 45. France Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Serum and Plasma Proteomics Service Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Serum and Plasma Proteomics Service Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 58. APAC Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 59. Europe Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 61. United States Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 62. Canada Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 63. Mexico Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 64. Brazil Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 65. China Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 66. Japan Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 67. Korea Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 69. India Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 70. Australia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 71. Germany Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 72. France Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 73. UK Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 74. Italy Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 75. Russia Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 76. Egypt Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 77. South Africa Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 78. Israel Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 79. Turkey Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
Figure 80. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Serum and Plasma Proteomics Service Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Serum and Plasma Proteomics Service Market Size 2027-2032 ($ millions)
